| Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection C Boni, P Fisicaro, C Valdatta, B Amadei, P Di Vincenzo, T Giuberti, ... Journal of virology 81 (8), 4215-4225, 2007 | 1131 | 2007 |
| Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B P Fisicaro, C Valdatta, M Massari, E Loggi, E Biasini, L Sacchelli, ... Gastroenterology 138 (2), 682-693. e4, 2010 | 556 | 2010 |
| Early kinetics of innate and adaptive immune responses during hepatitis B virus infection P Fisicaro, C Valdatta, C Boni, M Massari, C Mori, A Zerbini, A Orlandini, ... Gut 58 (7), 974-982, 2009 | 381 | 2009 |
| Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B P Fisicaro, V Barili, B Montanini, G Acerbi, M Ferracin, F Guerrieri, ... Nature medicine 23 (3), 327-336, 2017 | 324 | 2017 |
| Outcome of acute hepatitis C is related to virus‐specific CD4 function and maturation of antiviral memory CD8 responses S Urbani, B Amadei, P Fisicaro, D Tola, A Orlandini, L Sacchelli, C Mori, ... Hepatology 44 (1), 126-139, 2006 | 289 | 2006 |
| Activation of natural killer cells during acute infection with hepatitis C virus B Amadei, S Urbani, A Cazaly, P Fisicaro, A Zerbini, P Ahmed, G Missale, ... Gastroenterology 138 (4), 1536-1545, 2010 | 230 | 2010 |
| The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection A Zerbini, M Pilli, C Boni, P Fisicaro, A Penna, P Di Vincenzo, T Giuberti, ... Gastroenterology 134 (5), 1470-1481, 2008 | 195 | 2008 |
| Heterologous T cell immunity in severe hepatitis C virus infection S Urbani, B Amadei, P Fisicaro, M Pilli, G Missale, A Bertoletti, C Ferrari The Journal of experimental medicine 201 (5), 675-680, 2005 | 176 | 2005 |
| Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV P Fisicaro, C Valdatta, M Massari, E Loggi, L Ravanetti, S Urbani, ... Gastroenterology 143 (6), 1576-1585. e4, 2012 | 142 | 2012 |
| Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire AT Tan, E Loggi, C Boni, A Chia, AJ Gehring, KSR Sastry, V Goh, ... Journal of virology 82 (22), 10986-10997, 2008 | 139 | 2008 |
| Combined GS-4774 and tenofovir therapy can improve HBV-specific T-cell responses in patients with chronic hepatitis C Boni, HLA Janssen, M Rossi, SK Yoon, A Vecchi, V Barili, EM Yoshida, ... Gastroenterology 157 (1), 227-241. e7, 2019 | 133 | 2019 |
| Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design PWHI Parren, MC Gauduin, RA Koup, P Poignard, P Fisicaro, DR Burton, ... Immunology letters 57 (1-3), 105-112, 1997 | 112 | 1997 |
| Pathogenetic mechanisms of T cell dysfunction in chronic HBV infection and related therapeutic approaches P Fisicaro, V Barili, M Rossi, I Montali, A Vecchi, G Acerbi, D Laccabue, ... Frontiers in Immunology 11, 849, 2020 | 107 | 2020 |
| Acute phase HBV‐specific T cell responses associated with HBV persistence after HBV/HCV coinfection S Urbani, C Boni, B Amadei, P Fisicaro, S Cerioni, MA Valli, G Missale, ... Hepatology 41 (4), 826-831, 2005 | 105 | 2005 |
| Natural killer cell phenotype modulation and natural killer/T‐cell interplay in nucleos (t) ide analogue‐treated hepatitis e antigen‐negative patients with chronic hepatitis B C Boni, P Lampertico, L Talamona, T Giuberti, F Invernizzi, V Barili, ... Hepatology 62 (6), 1697-1709, 2015 | 89 | 2015 |
| The impairment of CD8 responses limits the selection of escape mutations in acute hepatitis C virus infection S Urbani, B Amadei, E Cariani, P Fisicaro, A Orlandini, G Missale, ... The Journal of Immunology 175 (11), 7519-7529, 2005 | 66 | 2005 |
| In vitro antigen challenge of human antibody libraries for vaccine evaluation: the human immunodeficiency virus type 1 envelope PW Parren, P Fisicaro, AF Labrijn, JM Binley, WP Yang, HJ Ditzel, ... Journal of virology 70 (12), 9046-9050, 1996 | 66 | 1996 |
| HBV immune-therapy: from molecular mechanisms to clinical applications C Boni, V Barili, G Acerbi, M Rossi, A Vecchi, D Laccabue, A Penna, ... International journal of molecular sciences 20 (11), 2754, 2019 | 61 | 2019 |
| Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection V Barili, P Fisicaro, B Montanini, G Acerbi, A Filippi, G Forleo, C Romualdi, ... Nature communications 11 (1), 604, 2020 | 48 | 2020 |
| Strategies to overcome HBV-specific T cell exhaustion: checkpoint inhibitors and metabolic re-programming P Fisicaro, C Boni, V Barili, D Laccabue, C Ferrari Current opinion in virology 30, 1-8, 2018 | 48 | 2018 |
